热景生物：关于参股公司增资扩股实施股权激励暨关联交易的公告

Core Points - The company announced a capital increase and equity incentive plan for its associate company, Beijing ShunJing Biological Pharmaceutical Technology Co., Ltd. [2] - The total amount of the capital increase is set at 40 million yuan, with 4 million new registered capital to be subscribed [2] - The company will waive its preferential subscription rights for this capital increase, which constitutes a related party transaction [2] Summary by Sections - Capital Increase and Equity Incentive The associate company, ShunJing Pharmaceutical, plans to establish a limited partnership for employee stock ownership to facilitate the capital increase and implement equity incentives [2] - Financial Details The total capital increase amount is 40 million yuan, with 4 million yuan allocated for new registered capital, while the remaining amount will be added to the capital reserve [2] - Related Party Transaction The company's controlling shareholder and actual controller, Lin Changqing, serves as the chairman of ShunJing Pharmaceutical, and he will also act as the general partner of the newly established employee stock ownership platform [2] The related party transaction requires approval from the shareholders' meeting [2]